UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vitamin D and Its Relationship with Obesity and Muscle

International Journal of Endocrinology, 2014-01, Vol.2014 (2014), p.1-11

2014

Volltextzugriff (PDF)

Effect of denosumab on circulating markers of atherosclerosis in women with postmenopausal osteoporosis

Bone Reports, 2020-10, Vol.13, p.100356, Article 100356

2020

Volltextzugriff (PDF)

The diagnosis and management of hypercalcaemia

BMJ (Online), 2015-06, Vol.350 (jun02 15), p.h2723-h2723

2015

Volltextzugriff (PDF)

The effect of parathyroidectomy on chronic constipation in patients affected by primary hyperparathyroidism

Journal of bone and mineral metabolism, 2013-11, Vol.31 (6), p.690-694

2013

Volltextzugriff (PDF)

Prevalence of Kidney Stones and Vertebral Fractures in Primary Hyperparathyroidism Using Imaging Technology

The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1309-1315

2015

Volltextzugriff (PDF)

“Trabecular Bone Score” (TBS): An indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism

Bone (New York, N.Y.), 2013-03, Vol.53 (1), p.154-159

2013

Volltextzugriff (PDF)

Long-Term Bioavailability After a Single Oral or Intramuscular Administration of 600,000 IU of Ergocalciferol or Cholecalciferol: Implications for Treatment and Prophylaxis

The journal of clinical endocrinology and metabolism, 2013-07, Vol.98 (7), p.2709-2715

2013

Volltextzugriff (PDF)

Emerging data on cardiovascular risk in primary hyperparathyroidism

Endocrine, 2014-11, Vol.47 (2), p.345-347

2014

Volltextzugriff (PDF)

Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study

Endocrine, 2021, Vol.71 (1), p.199-207

2021

Volltextzugriff (PDF)

Six-year follow-up of a characteristic osteolytic lesion in a patient with tumor-induced osteomalacia

European journal of endocrinology, 2014-01, Vol.170 (1), p.K1-K4

2014

Volltextzugriff (PDF)

Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation

European journal of endocrinology, 2013-10, Vol.169 (4), p.R59-R69

2013

Volltextzugriff (PDF)

Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study

European journal of endocrinology, 2014-10, Vol.171 (4), p.481-487

2014

Volltextzugriff (PDF)

Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test

European journal of endocrinology, 2013-08, Vol.169 (2), p.255-261

2013

Volltextzugriff (PDF)

The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture

Clinical endocrinology (Oxford), 2012-11, Vol.77 (5), p.672-678

2012

Volltextzugriff (PDF)

Secondary osteoporosis in men and women: clinical challenge of an unresolved issue

Journal of rheumatology, 2011-08, Vol.38 (8), p.1671-1679

2011

Volltextzugriff (PDF)

Arrhythmias in primary hyperparathyroidism evaluated by exercise test

European journal of clinical investigation, 2013-02, Vol.43 (2), p.208-214

2013

Volltextzugriff (PDF)

The Effects of Alendronate Treatment in Osteoporotic Patients Affected by Monoclonal Gammopathy of Undetermined Significance

Calcified tissue international, 2008-06, Vol.82 (6), p.418-426

2008

Volltextzugriff (PDF)

Quality of life in patients with primary hyperparathyroidism

Expert review of pharmacoeconomics & outcomes research, 2014-02, Vol.14 (1), p.113-121

2014

Volltextzugriff (PDF)

Sex hormones and bone health in males

Archives of biochemistry and biophysics, 2010-11, Vol.503 (1), p.110-117

2010

Volltextzugriff (PDF)

Metabolic Changes Following 500 μg Monthly Administration of Calcidiol: A Study in Normal Females

Calcified tissue international, 2011-09, Vol.89 (3), p.252-257

2011

Volltextzugriff (PDF)

Update on vitamin D: pros and cons

Clinical cases in mineral and bone metabolism, 2015-09, Vol.12 (3), p.222-223

2015

Volltextzugriff (PDF)

Osteoporosis intervention in ambulatory patients with previous hip fracture : a multicentric, nationwide Italian survey

Osteoporosis international, 2006-03, Vol.17 (3), p.478-483

2006

Volltextzugriff (PDF)

The combination of FRAX and A geing M ale S ymptoms scale better identifies treated HIV males at risk for major fracture

Clinical endocrinology (Oxford), 2012-11, Vol.77 (5), p.672-678

2012

Volltextzugriff (PDF)

Acute effect of zoledronic acid on the risk of cardiac dysrhythmias

Internal and emergency medicine, 2015-03, Vol.10 (2), p.151-156

2015

Volltextzugriff (PDF)

Metabolic Changes Following 500 [micro]g Monthly Administration of Calcidiol: A Study in Normal Females

Calcified tissue international, 2011-09, Vol.89 (3), p.252

2011

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(103)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Vitamin D and Its Relationship with Obesity and Muscle

Effect of denosumab on circulating markers of atherosclerosis in women with postmenopausal osteoporosis

The diagnosis and management of hypercalcaemia

The effect of parathyroidectomy on chronic constipation in patients affected by primary hyperparathyroidism

Prevalence of Kidney Stones and Vertebral Fractures in Primary Hyperparathyroidism Using Imaging Technology

“Trabecular Bone Score” (TBS): An indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism

Long-Term Bioavailability After a Single Oral or Intramuscular Administration of 600,000 IU of Ergocalciferol or Cholecalciferol: Implications for Treatment and Prophylaxis

Emerging data on cardiovascular risk in primary hyperparathyroidism

Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study

Six-year follow-up of a characteristic osteolytic lesion in a patient with tumor-induced osteomalacia

Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation

Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study

Parathyroidectomy eliminates arrhythmic risk in primary hyperparathyroidism, as evaluated by exercise test

The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture

Secondary osteoporosis in men and women: clinical challenge of an unresolved issue

Arrhythmias in primary hyperparathyroidism evaluated by exercise test

The Effects of Alendronate Treatment in Osteoporotic Patients Affected by Monoclonal Gammopathy of Undetermined Significance

Quality of life in patients with primary hyperparathyroidism

Sex hormones and bone health in males

Metabolic Changes Following 500 μg Monthly Administration of Calcidiol: A Study in Normal Females

Update on vitamin D: pros and cons

Osteoporosis intervention in ambulatory patients with previous hip fracture : a multicentric, nationwide Italian survey

The combination of FRAX and A geing M ale S ymptoms scale better identifies treated HIV males at risk for major fracture

Acute effect of zoledronic acid on the risk of cardiac dysrhythmias

Metabolic Changes Following 500 [micro]g Monthly Administration of Calcidiol: A Study in Normal Females

Suchergebnisse filtern